Share

July 28, 2020; 95 (4) Article

Healthy lifestyle and the risk of Alzheimer dementia

Findings from 2 longitudinal studies

Klodian Dhana, Denis A. Evans, Kumar B. Rajan, David A. Bennett, Martha C. Morris
First published June 17, 2020, DOI: https://doi.org/10.1212/WNL.0000000000009816
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
673

Share

Article Information

vol. 95 no. 4 e374-e383
DOI: 
https://doi.org/10.1212/WNL.0000000000009816
PubMed: 
32554763
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received July 11, 2019
  • Accepted in final form January 5, 2020
  • First Published June 17, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Klodian Dhana, MD, PhD,
    2. Denis A. Evans, MD,
    3. Kumar B. Rajan, PhD,
    4. David A. Bennett, MD and
    5. Martha C. Morris, ScD
  1. Klodian Dhana, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) National Institute on Aging R01AG052583 (Morris), Role: Project Director at the Assistant Professor level, Years: 04-01-2019 to 03-31-2021

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Denis A. Evans, MD,
    3. Scientific Advisory Boards:

    1. McGill University,Data Safety Monitoring Board, Investigations of Naproxen Treatment Effects in Pre-Clinical Alzheimer’s Disease (INTREPAD)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Principal Investigator or Co-Investigator of NIH grants AG11101, AG030146

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Co-Investigator of grant Alzheimer’s Association NIRG 302587

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Kumar B. Rajan, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Professor, University of California at Davis

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH grants - R01AG051635 (principal investigator, 2016-2021), RF1AG057532 (principal investigator, 2017-2021), R01AG058679 (principal investigator, 2019- 2024)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National Institutes of Health (R01AG051635, RF1AG057532, R01AG058679).

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. David A. Bennett, MD and
    5. Scientific Advisory Boards:

    1. (1) Vigorous Minds, Scientific Advisory Board (2) AbbVie - Data Monitoring Committee (3) EABs: India Institute of Science; MCSA; Columbia ADRC; CCNA; CIMA-Q, WFU, Emory, MODEL-AD, REGARDS (4) DMCs: HRS, MIDUS (5) National Advisory Council on Aging

    Gifts:

    1. $100,000 Potamkin Prize from the American Brain Foundation April 2018

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Neurology, Editorial Board; (2) Current Alzheimer Research, Editorial Board; (3) Neuroepidemiology, Editorial Board (4) Journal of the Prevention of Alzheimer's Disease, Editorial Board (5) Journal of Alzheimer's Disease, Editorial Board (6) Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Editorial Board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen - funding for analyses of our own data Neurovision - amyloid eye imaging

    Research Support, Government Entities:

    1. NIH: P30AG10161, PI; R01AG15819, PI; R01AG17917, PI; R01AG36042, MPI; R01AG54058, PI; U01AG61356, MPI; R01AG52476, MPI,

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Martha C. Morris, ScD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) National Institute on Aging 2) R01AG054476 3) Principal Investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Rush Institute for Healthy Aging (K.D., D.A.E., M.C.M.) and Rush Alzheimer's Disease Center (D.A.B.), Rush University Medical Center, Chicago, IL; and Department of Public Health Sciences (K.B.R.), University of California at Davis.
  1. Correspondence
    Dr. Dhana klodian_dhana{at}rush.edu
View Full Text

Article usage

Article usage: June 2020 to June 2022

AbstractFullPdfSource
Jun 202093260217Highwire
Jul 2020704194163Highwire
Aug 202023086182Highwire
Sep 202012803526Highwire
Oct 202014963420Highwire
Nov 202011085725Highwire
Dec 20205731613Highwire
Jan 2021699106Highwire
Feb 20216352012Highwire
Mar 20217042013Highwire
Apr 20216272113Highwire
May 20215831510Highwire
Jun 2021576149Highwire
Jul 202161387Highwire
Aug 2021528103Highwire
Sep 2021576223Highwire
Oct 2021751124Highwire
Nov 202179754Highwire
Dec 202170774Highwire
Jan 2022547165Highwire
Feb 2022577127Highwire
Mar 2022637104Highwire
Apr 20221062188Highwire
May 20227131710Highwire
Jun 202252385Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me